Twice-yearly blood pressure treatment could reshape hypertension care, but doctors warn against a “fire-and-forget” approach
Long-acting RNA interference therapy for hypertension could shift blood pressure control from daily pill-taking to scheduled, system-led protection. But the authors warn that this “vaccine-like” model must preserve lifestyle support,…